Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiyu He

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
BMC Cancer|August 23, 2024
Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosisChiyu He, Zhihang Hu, Zuyuan Lin, et al.
International Journal of Surgery (London, England)|March 15, 2024
The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort studyHao Chen, Zhihang Hu, Qingguo Xu, et al.
BMC Cancer|October 14, 2025
Machine learning predicts post-transplant muscle loss in hepatocellular carcinoma patients without sarcopeniaJinyan Chen, Zhihang Hu, Huigang Li, et al.
Acta Pharmaceutica Sinica. B|November 8, 2016
Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC-MS/MS: Rg1 excretion in rat bile, urine and fecesChiyu He, Ru Feng, Yupeng Sun, et al.
Transplant Immunology|June 12, 2024
Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinomaChiyu He, Wei Shen, Zuyuan Lin, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 28, 2024
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinomaDi Lu, Zhihang Hu, Hao Chen, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 13, 2025
HBV reactivation and its metabolomic profile after liver transplantation for hepatocellular carcinoma in non-alcoholic steatohepatitisJinyan Chen, Leyi Chen, Huigang Li, et al.
ILIVER|July 10, 2025
CCL16 inhibits tumor proliferation and metastasis in HCC by impacting CK19 phenotypeHuigang Li, Jianyong Zhuo, Peiru Zhang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 31, 2025
Mesenchymal circulating tumor cells as prognostic markers in HCC Post-Transplantation: Sirolimus as a potential therapeutic ModulatorJinyan Chen, Rongsen Wang, Huigang Li, et al.
International Journal of Surgery (London, England)|February 13, 2024
Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in ChinaHuigang Li, Di Lu, Jinyan Chen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
BMC Cancer|August 23, 2024
Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosisChiyu He, Zhihang Hu, Zuyuan Lin, et al.
International Journal of Surgery (London, England)|March 15, 2024
The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort studyHao Chen, Zhihang Hu, Qingguo Xu, et al.
BMC Cancer|October 14, 2025
Machine learning predicts post-transplant muscle loss in hepatocellular carcinoma patients without sarcopeniaJinyan Chen, Zhihang Hu, Huigang Li, et al.
Acta Pharmaceutica Sinica. B|November 8, 2016
Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC-MS/MS: Rg1 excretion in rat bile, urine and fecesChiyu He, Ru Feng, Yupeng Sun, et al.
Transplant Immunology|June 12, 2024
Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinomaChiyu He, Wei Shen, Zuyuan Lin, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 28, 2024
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinomaDi Lu, Zhihang Hu, Hao Chen, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 13, 2025
HBV reactivation and its metabolomic profile after liver transplantation for hepatocellular carcinoma in non-alcoholic steatohepatitisJinyan Chen, Leyi Chen, Huigang Li, et al.
ILIVER|July 10, 2025
CCL16 inhibits tumor proliferation and metastasis in HCC by impacting CK19 phenotypeHuigang Li, Jianyong Zhuo, Peiru Zhang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 31, 2025
Mesenchymal circulating tumor cells as prognostic markers in HCC Post-Transplantation: Sirolimus as a potential therapeutic ModulatorJinyan Chen, Rongsen Wang, Huigang Li, et al.
International Journal of Surgery (London, England)|February 13, 2024
Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in ChinaHuigang Li, Di Lu, Jinyan Chen, et al.
Pageof 3